Subscribe To
molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- molecular Templates, Inc. (Nasdaq: MTEM, “...
December 2, 2022, 5:02 pm
molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- molecular Templates, Inc. (Nasdaq: MTEM, “...
December 2, 2022, 5:02 pm
molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- molecular Templates, Inc. (Nasdaq: MTEM, “...
December 2, 2022, 5:02 pm
molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- molecular Templates, Inc. (Nasdaq: MTEM, “...
December 2, 2022, 5:02 pm
molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- molecular Templates, Inc. (Nasdaq: MTEM, “...
December 2, 2022, 5:02 pm
molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- molecular Templates, Inc. (Nasdaq: MTEM, “...
December 2, 2022, 5:02 pm
molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- molecular Templates, Inc. (Nasdaq: MTEM, “...
December 2, 2022, 5:02 pm
molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- molecular Templates, Inc. (Nasdaq: MTEM, “...
December 2, 2022, 5:02 pm
molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- molecular Templates, Inc. (Nasdaq: MTEM, “...
December 2, 2022, 5:02 pm
molecular templates, inc. to present interim results on mt-5111 at the 45th annual san antonio breast cancer symposium (sabcs) and participate at the 64th american society of hematology (ash) annual m
AUSTIN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- molecular Templates, Inc. (Nasdaq: MTEM, “...
December 2, 2022, 5:02 pm
Betterlife to present betr-001 preclinical data at the american college of neuropsychopharmacology meeting in phoenix
BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF) said that one of its scientific collaborators, Dr Argel Aguilar-Valles from Carleton University's Depart...
December 2, 2022, 9:25 am
Rapt therapeutics to present flx475 phase 1/2 data at the european society for medical oncology (esmo) immuno-oncology annual congress
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a clinical-s...
December 1, 2022, 12:05 am
Rapt therapeutics to present flx475 phase 1/2 data at the european society for medical oncology (esmo) immuno-oncology annual congress
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a clinical-s...
November 30, 2022, 7:05 pm
Regen biopharma, inc. to present at the emerging growth conference on november 30, 2022
Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts to attend its real-time interactive presentation...
November 28, 2022, 2:49 pm
Athira pharma to present preclinical data highlighting therapeutic potential of ath-1105 in als at the 33rd international symposium on als/mnd
HGF/MET small molecule positive modulator provides neuroprotection and improves motor and nerve functio...
November 28, 2022, 7:00 am
molecular templates, inc. to present fireside chats at two upcoming investor conferences: evercore isi's 5th annual healthconx conference and piper sandler's 34th annual healthcare conference
AUSTIN, Texas, Nov. 23, 2022 (GLOBE NEWSWIRE) -- molecular Templates, Inc. (Nasdaq: MTEM, “...
November 23, 2022, 4:30 pm
Xilio therapeutics to host live virtual program spotlighting xtx301, a tumor-activated il-12
WALTHAM, Mass., Nov. 23, 2022 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-activated immuno-o...
November 23, 2022, 12:30 pm
Urogen pharma: jelmyto sales growing steadily, concerns remain
Shares have lost nearly two-thirds of their value over the past 3 years. RTGel platform is a great fit for bladder cancers due to its ability to allow...
November 21, 2022, 1:30 pm
Gold coast keto gummies maggie beer australia reviews shocking shark tank exposed must read feedback and price?
This diet is not just about losing those fatty molecules from your body but also reducing the risk of m...
November 19, 2022, 7:33 pm
Cue health ceo on fda emergency authorization for covid at-home test
The FDA has granted emergency use authorization for Cue Health's rapid Covid test, making it the first mole...
November 19, 2022, 9:16 am